Marvin BurnsClinical NewsNew technology spurs investment in brachytherapyThe U.S. market for brachytherapy products should exceed $1 billion in the next five years, driven by the introduction of new products that allow accelerated treatment for cancer patients after surgery. The worldwide market could grow even more rapidly, according to this analysis from market research firm Bio-Tech Systems.April 22, 2009Page 1 of 1Top StoriesNuclear MedicineSPECT, PET refine contemporary cardiac amyloidosis assessmentExperts highlighted SPECT/SPECT-CT as central to reliable cardiac amyloidosis imaging, while emerging PET tracers may improve early detection, disease characterization, and follow-up.UltrasoundAdvanced ultrasound techniques improve soft tissue tumor evaluationNuclear MedicineSwiss nuclear medicine seeks rules fit for radiopharmaceutical innovationHomeLeimgruber: Nuclear medicine needs regulation fit for innovationHomeSuhny Abbara talks AI in scientific publishing